“"The Essex Woodlands team has added value to our company, and their industry knowledge and resources helped us to develop insight into new markets and territories."”
Albert Chen
Chief Financial Officer
China-based cord blood collector
Cord blood banking operator in China
China Cord Blood (NYSE: CO), was dedicated to the storage of umbilical cord blood stem cells and related services for parents and their children throughout China and the Asia Pacific regions, with its headquarters in Hong Kong. Cord blood and cord tissue are extremely valuable to parents and their children because of their ability to heal the body, promote recovery, and because of their incredible therapeutic potential across numerous indications from heart disease to stroke to spinal cord damage. China Cord Blood was the first cord blood banking operator approved by the Ministry of Health in China and had exclusive blood storage services in the Beijing Municipality, the Guangdong Province, and the Zhejiang Province, covering approximately half of total newborns in the regions licensed to provide cord blood banking services. EW exited its position effective April 2014.
“"The Essex Woodlands team has added value to our company, and their industry knowledge and resources helped us to develop insight into new markets and territories."”
Chief Financial Officer
Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.
All content © 2025
Legal Disclaimer | Privacy Notice
Powered by 